论文部分内容阅读
目的对120例药物流(引)产合用清宫术的安全性进行临床分析。方法随机抽取2010年至2011年期间需要进行流(引)产的患者240例,随机分为两组,对照组和改良组,每组各120例患者。对对照组中的患者采取传统的药物保守治疗,而对改良组中的患者采取药物引流合用清宫术处理。对两组患者的阴道流血停止时间以及宫内异常回声消失例数等进行了解,比较。结果对照组中,患者阴道流血停止时间为(3.5±1.2)d,撤退性出血后复查B超宫腔异常回声消失占89.17%,治愈的患者占92.50%;而改良组中患者阴道流血停止时间为(2.8±0.8)d,撤退性出血后复查B超宫腔异常回声消失占97.50%,治愈的患者占100.00%;即相对于对照组,改良组中的患者的引产质量较高,更为安全有效,差异有统计学意义(P<0.05)。结论在对产妇进行引产时,采取药物流产合用清宫术,更为安全有效,有一定的临床积极意义,值得推广。
Objective To analyze the safety of 120 cases of drug flow (lead) combined with curettage. Methods A total of 240 patients with flow (lead) production during 2010 to 2011 were randomly selected and randomly divided into two groups, control group and modified group, with 120 patients in each group. Patients in the control group were treated conservatively with traditional drugs, while patients in the modified group were treated with drug drainage combined with curettage. The two groups of patients with vaginal bleeding time and intrauterine anomalous echo disappear number of cases to understand and compare. Results In the control group, the duration of vaginal bleeding was (3.5 ± 1.2) days. After the withdrawal bleeding, 89.17% of the patients with abnormal uterine cavity echoes disappeared and 92.5% of the patients were cured. In the improved group, the time of vaginal bleeding was stopped (2.8 ± 0.8) d. After the withdrawal bleeding, the abnormal echo of B-uterus disappeared and accounted for 97.50%, and the cured patients accounted for 100.00%. Compared with the control group, the quality of induced labor in the improved group was higher Safe and effective, the difference was statistically significant (P <0.05). Conclusion Maternal induction of labor, the use of medical abortion combined with curettage, more safe and effective, has some clinical significance, it is worth promoting.